BTAI - BioXcel Therapeutics, Inc.
1.53
-0.050 -3.268%
Share volume: 68,452
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.58
-0.05
-0.03%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-09-2024 | 08-14-2023 | 11-14-2023 | 11-14-2024 | 05-09-2024 | 08-06-2024 | 11-14-2024 | 03-28-2025 | |
| Total revenue | 206.000 K | 457.000 K | 341.000 K | 376.000 K | 582.000 K | 1.104 M | 214.000 K | 366.000 K | |
| Cost of revenue | 9.000 K | 26.000 K | 512.000 K | 713.000 K | 80.000 K | 62.000 K | 1.170 M | 831.000 K | |
| Gross profit | 197.000 K | 431.000 K | -171.000 K | -337.000 K | 502.000 K | 1.042 M | -956.000 K | -465.000 K | |
| 118.78% | -139.68% | -97.08% | 248.96% | 107.57% | -191.75% | 51.36% | |||
| Operating expenses | 51.395 M | 52.845 M | 43.963 M | 19.536 M | 24.665 M | 17.482 M | 12.784 M | 9.996 M | |
| Selling general and admin | 23.595 M | 25.872 M | 24.344 M | 9.602 M | 13.264 M | 9.450 M | 7.683 M | 4.095 M | |
| Research and development | 27.800 M | 26.973 M | 19.619 M | 9.934 M | 11.401 M | 8.032 M | 5.101 M | 5.901 M | |
| Total expenses | 51.395 M | 52.845 M | 48.126 M | 19.536 M | 24.665 M | 18.338 M | 14.337 M | 10.028 M | |
| 2.82% | -8.93% | -59.41% | 26.25% | -25.65% | -21.82% | -30.06% | |||
| Operating income | -51.198 M | -52.414 M | -48.297 M | -19.873 M | -24.163 M | -17.296 M | -15.293 M | -10.493 M | |
| Ebit | -51.444 M | -51.877 M | -48.302 M | -19.765 M | -24.131 M | -5.270 M | -10.476 M | -7.195 M | |
| Pretax income | -52.796 M | -53.515 M | -50.486 M | -22.256 M | -26.791 M | -8.299 M | -13.650 M | -10.859 M | |
| 1.36% | -5.66% | -55.92% | 20.38% | -69.02% | 64.48% | -20.45% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -52.796 M | -53.515 M | -50.486 M | -22.256 M | -26.791 M | -8.299 M | -13.650 M | -10.859 M | |
| -1.36% | 5.66% | 55.92% | -20.38% | 69.02% | -64.48% | 20.45% |
